Repeat adverse drug reactions causing hospitalization in older Australians: a population‐based longitudinal study 1980–2003
Open Access
- 22 December 2006
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 63 (2) , 163-170
- https://doi.org/10.1111/j.1365-2125.2006.02839.x
Abstract
What is already known about this subject • Adverse drug reactions (ADRs) are a major cause of morbidity in older patients and represent a major burden on healthcare.• The rate of ADR‐related hospital stays in older people in Western Australia (WA) increased fivefold from 1981 to 2002.• Little information is available regarding repeated ADRs in the elderly and the drugs most responsible. What this study adds • Repeat ADR‐related hospitalizations have consistently increased faster than first‐time ADRs in the elderly in WA from 1980 and had reached 30.3% of all ADRs by 2003.• The mean time interval declined with each successive repeat ADR and the most common repeat ADRs were nausea and vomiting, haemorrhage due to anticoagulants, drug‐induce osteoporosis and poisoning by cardiovascular agents.• Strategies to ensure the safer use cardiovascular agents, corticoids, nonsteroidal anti‐inflammatory drugs, opioids and, in particular, anticoagulants, in this population are warranted.Aim To examine trends in the rate of repeat adverse drug reactions (ADRs) causing hospitalization in older Australians and to identify the most common ADRs and drugs most often implicated in repeat and first‐time ADRs.Methods: Analysis of routinely collected hospital record administrative data, with International Classification of Diseases external cause codes for ADRs extracted from the Western Australia (WA) Hospital Morbidity Data System and WA Death Register, for people aged ≥60 years in 1980–2003.Results: A total of 37 296 people aged ≥60 years with an ADR‐related hospitalization were identified. Among them, 6853 (18.4%) patients had 10 212 repeat ADRs. Repeat ADRs consistently increased from 1980 and reached 30.3% of all ADRs by 2003. The mean time interval declined with each successive repeat ADR (810, 606 and 299 days for the first, second and higher ranked repeat episodes, respectively). The most common repeat ADRs were nausea/vomiting (8.0%), haemorrhage due to anticoagulants (5.5%), drug‐induced osteoporosis (4.8%) and poisoning by cardiovascular agents (3.9%). The drugs most often involved in repeat ADRs were cardiovascular agents (15.6%), antineoplastic drugs (11.0%), corticoids (10.1%), anticoagulants (8.6%), antirheumatics/nonsteroidal anti‐inflammatory drugs (5.1%) and opioids (4.9%). The trends of anticoagulants and antineoplastic drugs implicated in repeat ADRs were still rising at the end of the study. The specific drug classes involved in repeat ADRs differed in relative importance from first‐time ADRs.Conclusions: Repeat ADR‐related hospitalizations have consistently increased in elderly Australians from 1980 to 2003. Strategies to ensure the safer use of medicines, in particular anticoagulants, in this population are warranted.Keywords
This publication has 24 references indexed in Scilit:
- Complimentary and alternative medicine use among patients starting warfarinBritish Journal of Haematology, 2005
- The Association of Inappropriate Drug Use with Hospitalisation and MortalityDrugs & Aging, 2005
- Adverse Drug Reactions in an Elderly Hospitalised PopulationDrugs & Aging, 2005
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004
- Readmissions and adverse drug reactions in internal medicine: the economic impactJournal of Internal Medicine, 2004
- Adverse drug reactions in elderly patientsBritish Journal of Clinical Pharmacology, 2003
- The potential for adverse drug reactions in elderly patientsApplied Nursing Research, 2001
- The nature and extent of drug‐related hospitalisations in AustraliaJournal of Quality In Clinical Practice, 1999
- Incidence of Adverse Drug Reactions in Hospitalized PatientsJAMA, 1998
- Frequency and cost of serious adverse drug reactions in a department of general medicineBritish Journal of Clinical Pharmacology, 1998